Universidade NOVA de Lisboa has developed a decentralized thermal energy storage research project for the agroindustry that utilizes Phase Change Materials (PCMs) integrated directly into existing production equipment. This approach provides higher energy density than traditional sensible heat storage, such as water jackets, enabling more efficient energy use, reduced production costs, and improved sustainability for industrial heat-based processes.
Researchers at Universidade NOVA de Lisboa have developed a decentralized thermal energy storage architecture for the agroindustry sector. This research focuses on integrating Phase Change Materials (PCMs) directly into existing production equipment—such as tempering and mixing machines—to store thermal energy as latent heat. This approach offers a more efficient alternative to conventional, centralized sensible heat storage systems that typically rely on large volumes of water. By decentralizing storage, the technology allows agroindustrial facilities to improve energy efficiency, enhance operational sustainability, and reduce reliance on external energy sources.
The solution replaces or augments traditional sensible heat storage, such as water-jacketed heating systems, with inorganic or organic phase change materials.
The technology is currently in the development and validation phase, corresponding to a TRL of 4-5. The research team has successfully conducted computational modeling and simulation of the PCM-integrated architecture, followed by the development and laboratory testing of an instrumented prototype to validate the simulation models and assess performance gains. The work remains at the research and demonstration stage.
NOVA University Lisbon is a comprehensive public research institution spanning multiple campuses across the Lisbon metro area, combining selective excellence with an applied, collaborative ethos. Industry engages through co‑located laboratories at FCT NOVA and a science and technology park adjacent to the Caparica campus, alongside structured corporate partnership programs. Clinical translation is enabled by NOVA Medical School’s integration with Lisbon’s hospital network and clinical academic consortia, providing access to patient populations and real‑world settings. Research is supported by competitive European and Portuguese national funding, including Horizon Europe and the Foundation for Science and Technology, complemented by industry‑sponsored work. University‑wide innovation offices and school‑level TTOs provide IP, licensing, and startup support as a clear entry point for corporate R&D.